newsfilter
← Latest News
Business Wire·

Axcella Therapeutics Announces Appointment of New Chief Financial Officer

Axcella Therapeutics (NASDAQ:AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions, today announced the appointment of Robert Crane as the